MTI Outlook 2020: Changing China Is Opening Up For Medtech Entrants
The barriers for health-care industry entrants into China are lowering, but still not as quickly as many medtech companies would like. New structural health-care delivery plans are instilling more confidence in a market and industry that in the past have been regarded with caution.
You may also be interested in...
To the watching world, China dealt quickly and firmly with COVID-19. Seen from within, the health care system is still adapting to the pandemic, but the government is taking the longer view.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Later market launch of innovations and a hit on EBITDA are simultaneously affecting medtech companies in Germany and central Europe as they strive to keep quality uppermost while battling the most frustrating confluence of negative effects on business than most companies have ever seen.